Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Danziger SA"'
Autor:
Kessler, A, Dankwa, S, Bernabeu, M, Harawa, V, Danziger, SA, Duffy, F, Kampondeni, SD, Potchen, MJ, Dambrauskas, N, Vigdorovich, V, Oliver, BG, Hochman, SE, Mowrey, WB, MacCormick, IJC, Mandala, WL, Rogerson, SJ, Sather, DN, Aitchison, JD, Taylor, TE, Seydel, KB, Smith, JD, Kim, K
© 2017 Elsevier Inc. Brain swelling is a major predictor of mortality in pediatric cerebral malaria (CM). However, the mechanisms leading to swelling remain poorly defined. Here, we combined neuroimaging, parasite transcript profiling, and laborator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::e53b49eacd8a4c51e9e699868aa7979f
https://hdl.handle.net/10453/125024
https://hdl.handle.net/10453/125024
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Stokes ME; Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ, USA., Wenzl K; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Huang CC; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Ortiz M; Informatics and Predictive Sciences, Bristol Myers Squibb, Seville, Spain., Hsu CC; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Stong N; Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ, USA., Nakayama Y; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Wu L; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Chiu H; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Polonskaia A; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Danziger SA; BMS at the time the study was conducted, Amazon, Seattle, WA, USA., Towfic F; BMS at the time the study was conducted, Prometheus Biosciences, San Diego, CA, USA., Parker J; LifeEDIT Therapeutics, Research Triangle Park, Durham, NC, USA., King RL; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Link BK; Division of Hematology, Oncology, Blood and Marrow Transplant, University of Iowa, Iowa City, IA, USA., Slager SL; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Sarangi V; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Asmann YW; Department of Health Science Research, Mayo Clinic, Jacksonville, FL, USA., Novak JP; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Sudhindra A; Clinical Research and Development, Bristol Myers Squibb, Summit, NJ, USA., Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Habermann TM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hagner PR; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Cerhan JR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Novak AJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gandhi AK; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA. anita.gandhi@bms.com.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 08; Vol. 15 (1), pp. 6790. Date of Electronic Publication: 2024 Aug 08.
Autor:
Wall MA; Institute for Systems Biology, Seattle, WA, USA., Turkarslan S; Institute for Systems Biology, Seattle, WA, USA., Wu WJ; Institute for Systems Biology, Seattle, WA, USA., Danziger SA; Bristol-Myers Squibb, Summit, NJ, USA., Reiss DJ; Bristol-Myers Squibb, Summit, NJ, USA., Mason MJ; Sage Bionetworks, Seattle, WA, USA., Dervan AP; Bristol-Myers Squibb, Summit, NJ, USA., Trotter MWB; Celgene Institute for Translational Research Europe (CITRE), a Bristol-Myers Squibb Company, Summit, NJ, USA., Bassett D; Bristol-Myers Squibb, Summit, NJ, USA., Hershberg RM; Celgene Corporation, Seattle, WA, USA., Lomana ALG; Institute for Systems Biology, Seattle, WA, USA. adrian.lopezgarciadelomana@isbscience.org., Ratushny AV; Bristol-Myers Squibb, Summit, NJ, USA. alexander.ratushnyy@bms.com., Baliga NS; Institute for Systems Biology, Seattle, WA, USA. nitin.baliga@isbscience.org.; Departments of Biology, Microbiology, and Molecular Engineering Sciences, University of Washington, Seattle, WA, USA. nitin.baliga@isbscience.org.; Lawrence Berkeley National Labs, Berkeley, CA, USA. nitin.baliga@isbscience.org.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2021 Jun 28; Vol. 5 (1), pp. 60. Date of Electronic Publication: 2021 Jun 28.
Autor:
Neal ML; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA., Wei L; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA., Peterson E; Institute for Systems Biology, Seattle, WA, USA., Arrieta-Ortiz ML; Institute for Systems Biology, Seattle, WA, USA., Danziger SA; Center for Infectious Disease Research, Seattle, WA, USA., Baliga NS; Institute for Systems Biology, Seattle, WA, USA., Kaushansky A; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.; Brotman Baty Institute, Seattle, WA, USA., Aitchison JD; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA.; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2021 May 21; Vol. 49 (9), pp. 4891-4906.
Autor:
Danziger SA; Bristol Myers Squibb, Seattle, Washington, United States of America., McConnell M; Bristol Myers Squibb, Seattle, Washington, United States of America., Gockley J; Sage Bionetworks, Seattle, Washington, United States of America., Young MH; Sage Bionetworks, Seattle, Washington, United States of America., Rosenthal A; Cancer Research and Biostatistics, Seattle, Washington, United States of America., Schmitz F; Sage Bionetworks, Seattle, Washington, United States of America., Reiss DJ; Bristol Myers Squibb, Seattle, Washington, United States of America., Farmer P; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Alapat DV; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Singh A; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Ashby C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Bauer M; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Ren Y; Bristol Myers Squibb, Seattle, Washington, United States of America., Smith K; Bristol Myers Squibb, Seattle, Washington, United States of America., Couto SS; Genmab, Princeton, New Jersey, United States., van Rhee F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Davies F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Zangari M; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Petty N; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Orlowski RZ; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Dhodapkar MV; Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America., Copeland WB; Bristol Myers Squibb, Seattle, Washington, United States of America., Fox B; Bristol Myers Squibb, Seattle, Washington, United States of America., Hoering A; Cancer Research and Biostatistics, Seattle, Washington, United States of America., Fitch A; Bristol Myers Squibb, Seattle, Washington, United States of America., Newhall K; Sage Bionetworks, Seattle, Washington, United States of America., Barlogie B; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America., Trotter MWB; BMS Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Hershberg RM; Sage Bionetworks, Seattle, Washington, United States of America., Walker BA; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Dervan AP; Sage Bionetworks, Seattle, Washington, United States of America., Ratushny AV; Bristol Myers Squibb, Seattle, Washington, United States of America., Morgan GJ; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Publikováno v:
PLoS medicine [PLoS Med] 2020 Nov 04; Vol. 17 (11), pp. e1003323. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2020).
Autor:
Aguilar B; Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA., Gibbs DL; Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA., Reiss DJ; Bristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA., McConnell M; Bristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA., Danziger SA; Bristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA., Dervan A; Bristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA., Trotter M; BMS Center for Innovation and Translational Research Europe (CITRE), Pabellon de Italia, Calle Isaac Newton 4, Sevilla 41092, Spain., Bassett D; Bristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA., Hershberg R; Formerly Celgene Corporation, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA., Ratushny AV; Bristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA., Shmulevich I; Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA.
Publikováno v:
GigaScience [Gigascience] 2020 Jul 01; Vol. 9 (7).
Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease.
Autor:
Mason MJ; Sage Bionetworks, Seattle, WA, USA. michael.mason@sagebase.org., Schinke C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Eng CLP; Computational & Systems Biology, Genome Institute of Singapore, Singapore, Singapore., Towfic F; Celgene Corporation, Summit, NJ, USA., Gruber F; GNS Healthcare, Cambridge, MA, USA., Dervan A; Celgene, Seattle, WA, USA., White BS; Sage Bionetworks, Seattle, WA, USA., Pratapa A; Department of Computer Science, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA., Guan Y; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI, USA., Chen H; Shanghai Jiao Tong University, Shanghai, China., Cui Y; Stanford University School of Medicine, Palo Alto, CA, USA., Li B; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA., Yu T; Sage Bionetworks, Seattle, WA, USA., Chaibub Neto E; Sage Bionetworks, Seattle, WA, USA., Mavrommatis K; Celgene Corporation, Summit, NJ, USA., Ortiz M; Predictive Sciences, Celgene Corporation, Seville, Spain., Lyzogubov V; University of Arkansas for Medical Sciences, Little Rock, AR, USA., Bisht K; Celgene Corporation, Summit, NJ, USA., Dai HY; M2Gen, Tampa, FL, USA., Schmitz F; Celgene, Seattle, WA, USA., Flynt E; Celgene Corporation, Summit, NJ, USA., Dan Rozelle; Rancho BioSciences, San Diego, CA, USA., Danziger SA; Celgene, Seattle, WA, USA., Ratushny A; Celgene, Seattle, WA, USA., Dalton WS; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Goldschmidt H; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Avet-Loiseau H; Institut Universitaire du Cancer Oncopole, Toulouse, France., Samur M; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA., Hayete B; GNS Healthcare, Cambridge, MA, USA., Sonneveld P; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Shain KH; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.; Tumor Biology Department, Moffitt Cancer Center, Tampa, FL, USA., Munshi N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; VA Boston Healthcare System, Boston, MA, USA., Auclair D; Multiple Myeloma Research Foundation, Norwalk, CT, USA., Hose D; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.; Labor für Myelomforschung, Universitätsklinikum Heidelberg, Heidelberg, Germany., Morgan G; University of Arkansas for Medical Sciences, Little Rock, AR, USA., Trotter M; Predictive Sciences, Celgene Corporation, Seville, Spain., Bassett D; Celgene, Seattle, WA, USA., Goke J; Computational & Systems Biology, Genome Institute of Singapore, Singapore, Singapore., Walker BA; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Division of Hematology Oncology, Indiana University, Indianapolis, IN, USA., Thakurta A; Celgene Corporation, Summit, NJ, USA., Guinney J; Sage Bionetworks, Seattle, WA, USA.
Publikováno v:
Leukemia [Leukemia] 2020 Jul; Vol. 34 (7), pp. 1866-1874. Date of Electronic Publication: 2020 Feb 14.
Autor:
Danziger SA; Celgene Corporation, Seattle, Washington, United States of America., Gibbs DL; Institute for Systems Biology, Seattle, Washington, United States of America., Shmulevich I; Institute for Systems Biology, Seattle, Washington, United States of America., McConnell M; Celgene Corporation, Seattle, Washington, United States of America., Trotter MWB; Celgene Corporation, Seattle, Washington, United States of America.; Celgene Institute for Translational Research Europe, Seville, Sevilla, Spain., Schmitz F; Celgene Corporation, Seattle, Washington, United States of America., Reiss DJ; Celgene Corporation, Seattle, Washington, United States of America., Ratushny AV; Celgene Corporation, Seattle, Washington, United States of America.
Publikováno v:
PloS one [PLoS One] 2019 Nov 19; Vol. 14 (11), pp. e0224693. Date of Electronic Publication: 2019 Nov 19 (Print Publication: 2019).
Autor:
Zuck M; Center for Infectious Disease Research, formerly Seattle Biomedical Research Institute, Seattle, WA, United States., Austin LS; Center for Infectious Disease Research, formerly Seattle Biomedical Research Institute, Seattle, WA, United States., Danziger SA; Center for Infectious Disease Research, formerly Seattle Biomedical Research Institute, Seattle, WA, United States.; Institute for Systems Biology, Seattle, WA, United States., Aitchison JD; Center for Infectious Disease Research, formerly Seattle Biomedical Research Institute, Seattle, WA, United States.; Institute for Systems Biology, Seattle, WA, United States., Kaushansky A; Center for Infectious Disease Research, formerly Seattle Biomedical Research Institute, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States.
Publikováno v:
Frontiers in microbiology [Front Microbiol] 2017 Nov 16; Vol. 8, pp. 2183. Date of Electronic Publication: 2017 Nov 16 (Print Publication: 2017).